This is my testimony that I presented to the FDA at the recent hearings on the use of social communications in pharma. This specifically addressed FDA's question regarding "what parameters should apply to the posting of corrective information on Web sites controlled by third parties?" Download a copy of the presentation here: http://bit.ly/29OrtX
Link to this comment:
All Comments (0)